Guangjie Jin
Overview
Explore the profile of Guangjie Jin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huo X, Cui L, Zhu L, Zhang J, Fan H, Yi Y, et al.
J Infect Dev Ctries
. 2025 Jan;
18(12.1):S214-S226.
PMID: 39863937
Introduction: China implemented a dynamic zero-COVID strategy to curb viral transmission in response to the coronavirus disease 2019 (COVID-19) pandemic. This strategy was designed to inhibit mutation of severe acute...
2.
Li X, Ma Y, Li G, Jin G, Xu L, Li Y, et al.
Front Immunol
. 2024 Mar;
15:1298749.
PMID: 38440733
Since the leprosy cases have fallen dramatically, the incidence of leprosy has remained stable over the past years, indicating that multidrug therapy seems unable to eradicate leprosy. More seriously, the...
3.
Xu L, Jin G, Li X, Shao Y, Li Y, Zhang L
Healthcare (Basel)
. 2023 Dec;
11(23).
PMID: 38063627
Objectives: The study explores the relationship between social support, self-care ability, and life quality of cured leprosy patients (CLPs), aiming to develop strategies to enhance their overall well-being. Methods: From...
4.
Li X, Jin G, Yang J, Li Y, Wei P, Zhang L
Front Public Health
. 2023 Jan;
10:991828.
PMID: 36711406
Background: Jiangsu Province is located in the Yangtze River Delta region, with a total area of 107,200 square kilometers. Since 1949, over 55,000 cases have been registered, with Taixing accounting...
5.
Li X, Li G, Yang J, Jin G, Shao Y, Li Y, et al.
Int J Mol Sci
. 2022 Oct;
23(20).
PMID: 36293307
Dapsone (DDS), Rifampicin (RIF) and Ofloxacin (OFL) are drugs recommended by the World Health Organization (WHO) for the treatment of leprosy. In the context of leprosy, resistance to these drugs...
6.
Li X, Yang J, Zhang L, Jin G, Xu L, Fang F, et al.
Int J Environ Res Public Health
. 2022 Jul;
19(14).
PMID: 35886085
In recent years, after the essential elimination of leprosy (the prevalence of which is <1/100,000), the trends, research hotpots, and frontiers of leprosy research are not clear. This study provides...
7.
Yang J, Li X, Sun Y, Zhang L, Jin G, Li G, et al.
Pathog Glob Health
. 2022 May;
116(8):467-476.
PMID: 35510339
The objectives of this study were to explore global epidemiological characteristics of leprosy, and to provide reference for the construction of prevention strategies for leprosy. Computer retrieval of the study...